Briacell Therapeutics Corp BCTX

$3.41 -0.19 (-5.28%)

Valuation

Market cap
30,101,000
Revenue TTM
$0
Net income TTM
$-26,310,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
61,700
Avg volume
312,132
Day's range
$3.40 – $3.67
Shares out
8,700,000
Stochastic %K
38%
Beta
1.21
Analysts
Strong Buy
Price target
$40.00

Price

Company profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator...

Show more

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate the clinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
604 921 1810
Website
https://briacell.com
Address
Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada

Latest news

Stocktwits

Dragonfly41 Oct 22, 2:41 PM
$BCTX KPTI
0 replies
SmallCapVoice Oct 22, 11:33 AM
Dr. William Williams, CEO of $BCTX , joins The Bio Report podcast to discuss “Developing an Off-the-Shelf Cell-Based Immunotherapy for Metastatic Breast Cancer.” Listen to the interview and explore more BriaCell media coverage: https://briacell.com/media-coverage/
1 replies
AliceFireSteam Oct 21, 9:31 PM
$BCTX 2026 October – Dr. Williams’ interview at The Bio Report podcast added
2 replies
smallpower17 Oct 21, 6:41 PM
$BCTX https://finance.biggo.com/news/6eae7c836f271f71
0 replies
Rohtan Oct 21, 12:39 PM
$BCTX waiting for high 1s or low 2s to add . GL everyone
1 replies
DunkenInvest Oct 21, 9:38 AM
$BCTX spikes up to 3,89$ already in premarket, it looks like were going back to 4$ soon 💪🏽
1 replies
Dragonfly41 Oct 20, 9:23 PM
$BCTX KPTI
1 replies
BCTX20bMC Oct 20, 5:25 PM
$BCTX Moderna is now a 96b co…..after positive P3 data…never sell your shares.
0 replies